Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00302770
Status:
TERMINATED
Last Update Posted:
2011-01-27
First Post:
2006-03-13
Brief Title:
Efficacy of Quetiapine in Generalised Social Anxiety Disorder
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Efficacy of Quetiapine in Generalised Social Anxiety Disorder a Double-blind Placebo-controlled Study
Status:
TERMINATED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
This study was terminated due to poor enrollment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial will explore the efficacy of quetiapine in Social Anxiety Disorder generalized type The following elements of response will be tested number of responders to treatment time to response effect size as measured with the LSAS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None